Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

April 30, 2005

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Immunotherapy allogeneic GM-CSF secreting cellular vaccine

Trial Locations (12)

19111

Fox Chase cancer Center, Philadelphia

30322

Emory University, Atlanta

33180

South Florida Medical Research, Aventura

46825

Northeast Indiana Research, Fort Wayne

48109

University of Michigan Medical Center, Ann Arbor

61801

Carle Cancer Center, Urbana

78229

Urology San Antonio, San Antonio

91356

West Coast Clinical Research, Tarzana

92637

South Orange County Medical Research Center, Laguna Woods

94115

UCSF, San Francisco

98101

Virginia Mason Med. Crt., Seattle

98109

Seattle Cancer Care Alliance, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cell Genesys

INDUSTRY